A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer
Clinical trial NCT02081495 · COMPLETED
Trial details
- NCT number
- NCT02081495
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-11-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.